Altre lingue Terns Pharmaceuticals, Inc.

Azioni

TERN

US8808811074

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 03/05/2024			Variaz. 5gg	Var. 1 gen.
5,44 ^USD	+2,84%		+10,79%	-16,18%

29/04	Terns Pharmaceuticals, Inc. annuncia i dati dello studio farmacocinetico di Fase 1 in corso sull'inibitore allosterico di BCR-ABL Tern-701 in volontari adulti sani e mette in evidenza il potenziale di differenziazione competitiva	CI
10/04	Terns Pharmaceuticals, Inc. nomina Melita Sun Jung come Chief Business Officer	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	03/05
Terns Pharmaceuticals : Corporate Presentation April 2024	29/04
Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation	29/04
Terns Pharmaceuticals, Inc. Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor Tern-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation	29/04
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer	10/04
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer	10/04
Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer	10/04
North American Morning Briefing : Stocks Struggle After New Records	22/03
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates	14/03
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/03
Thinking about buying stock in Marathon Digital, Assertio, Ocean Biomedical, Terns Pharmaceuticals, or NextCure?	12/03
Terns Pharmaceuticals Gets Orphan Drug Label for Chronic Myeloid Leukemia Treatment Candidate	11/03
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia	11/03
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)	08/03
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	07/03
Terns Pharmaceuticals : Corporate Presentation March 2024	04/03
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences	27/02
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW CHIEF EXECUTIVE OFFICER UNDER NASDAQ LISTING RULE 5635(4)	08/02
Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)	07/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Terns Pharmaceuticals, Inc.

Azioni

TERN

US8808811074

Altre lingue

Filtri